nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Microtubule Inhibition—Eribulin—breast cancer	0.229	0.503	CiPCiCtD
Ixabepilone—Microtubule Inhibition—Paclitaxel—breast cancer	0.132	0.289	CiPCiCtD
Ixabepilone—TUBB3—breast cancer	0.12	0.867	CbGaD
Ixabepilone—Microtubule Inhibition—Docetaxel—breast cancer	0.0952	0.209	CiPCiCtD
Ixabepilone—CYP3A4—breast cancer	0.0184	0.133	CbGaD
Ixabepilone—TUBB2B—Eribulin—breast cancer	0.0141	0.047	CbGbCtD
Ixabepilone—TUBB6—Eribulin—breast cancer	0.0141	0.047	CbGbCtD
Ixabepilone—TUBB2A—Eribulin—breast cancer	0.0141	0.047	CbGbCtD
Ixabepilone—TUBB3—Eribulin—breast cancer	0.0141	0.047	CbGbCtD
Ixabepilone—TUBB4A—Eribulin—breast cancer	0.0141	0.047	CbGbCtD
Ixabepilone—TUBB8—Eribulin—breast cancer	0.0141	0.047	CbGbCtD
Ixabepilone—TUBB—Eribulin—breast cancer	0.0118	0.0393	CbGbCtD
Ixabepilone—TUBB1—Eribulin—breast cancer	0.0118	0.0393	CbGbCtD
Ixabepilone—TUBB4B—Eribulin—breast cancer	0.0118	0.0393	CbGbCtD
Ixabepilone—TUBB3—Vinorelbine—breast cancer	0.00722	0.0241	CbGbCtD
Ixabepilone—TUBB2A—Vinorelbine—breast cancer	0.00722	0.0241	CbGbCtD
Ixabepilone—TUBB6—Vinorelbine—breast cancer	0.00722	0.0241	CbGbCtD
Ixabepilone—TUBB8—Vinorelbine—breast cancer	0.00722	0.0241	CbGbCtD
Ixabepilone—TUBB4A—Vinorelbine—breast cancer	0.00722	0.0241	CbGbCtD
Ixabepilone—TUBB2B—Vinorelbine—breast cancer	0.00722	0.0241	CbGbCtD
Ixabepilone—TUBB—Vinorelbine—breast cancer	0.00604	0.0201	CbGbCtD
Ixabepilone—TUBB1—Vinorelbine—breast cancer	0.00604	0.0201	CbGbCtD
Ixabepilone—TUBB4B—Vinorelbine—breast cancer	0.00604	0.0201	CbGbCtD
Ixabepilone—TUBB4A—Paclitaxel—breast cancer	0.00507	0.0169	CbGbCtD
Ixabepilone—TUBB2B—Paclitaxel—breast cancer	0.00507	0.0169	CbGbCtD
Ixabepilone—TUBB3—Paclitaxel—breast cancer	0.00507	0.0169	CbGbCtD
Ixabepilone—TUBB8—Paclitaxel—breast cancer	0.00507	0.0169	CbGbCtD
Ixabepilone—TUBB6—Paclitaxel—breast cancer	0.00507	0.0169	CbGbCtD
Ixabepilone—TUBB2A—Paclitaxel—breast cancer	0.00507	0.0169	CbGbCtD
Ixabepilone—TUBB8—Vinblastine—breast cancer	0.00445	0.0148	CbGbCtD
Ixabepilone—TUBB2B—Vinblastine—breast cancer	0.00445	0.0148	CbGbCtD
Ixabepilone—TUBB4A—Vinblastine—breast cancer	0.00445	0.0148	CbGbCtD
Ixabepilone—TUBB3—Vinblastine—breast cancer	0.00445	0.0148	CbGbCtD
Ixabepilone—TUBB6—Vinblastine—breast cancer	0.00445	0.0148	CbGbCtD
Ixabepilone—TUBB2A—Vinblastine—breast cancer	0.00445	0.0148	CbGbCtD
Ixabepilone—TUBB1—Paclitaxel—breast cancer	0.00424	0.0141	CbGbCtD
Ixabepilone—TUBB4B—Paclitaxel—breast cancer	0.00424	0.0141	CbGbCtD
Ixabepilone—TUBB—Paclitaxel—breast cancer	0.00424	0.0141	CbGbCtD
Ixabepilone—TUBB4B—Vinblastine—breast cancer	0.00372	0.0124	CbGbCtD
Ixabepilone—TUBB1—Vinblastine—breast cancer	0.00372	0.0124	CbGbCtD
Ixabepilone—TUBB—Vinblastine—breast cancer	0.00372	0.0124	CbGbCtD
Ixabepilone—TUBB6—Docetaxel—breast cancer	0.00367	0.0122	CbGbCtD
Ixabepilone—TUBB8—Docetaxel—breast cancer	0.00367	0.0122	CbGbCtD
Ixabepilone—TUBB4A—Docetaxel—breast cancer	0.00367	0.0122	CbGbCtD
Ixabepilone—TUBB2B—Docetaxel—breast cancer	0.00367	0.0122	CbGbCtD
Ixabepilone—TUBB3—Docetaxel—breast cancer	0.00367	0.0122	CbGbCtD
Ixabepilone—TUBB2A—Docetaxel—breast cancer	0.00367	0.0122	CbGbCtD
Ixabepilone—TUBB1—Docetaxel—breast cancer	0.00307	0.0102	CbGbCtD
Ixabepilone—TUBB4B—Docetaxel—breast cancer	0.00307	0.0102	CbGbCtD
Ixabepilone—TUBB—Docetaxel—breast cancer	0.00307	0.0102	CbGbCtD
Ixabepilone—CYP3A4—Exemestane—breast cancer	0.000918	0.00306	CbGbCtD
Ixabepilone—CYP3A4—Letrozole—breast cancer	0.000781	0.0026	CbGbCtD
Ixabepilone—CYP3A4—Anastrozole—breast cancer	0.000696	0.00232	CbGbCtD
Ixabepilone—CYP3A4—Toremifene—breast cancer	0.000636	0.00212	CbGbCtD
Ixabepilone—CYP3A4—Fulvestrant—breast cancer	0.000592	0.00197	CbGbCtD
Ixabepilone—CYP3A4—Thiotepa—breast cancer	0.000527	0.00176	CbGbCtD
Ixabepilone—CYP3A4—Lapatinib—breast cancer	0.000464	0.00155	CbGbCtD
Ixabepilone—TUBB6—mammary gland—breast cancer	0.000457	0.0306	CbGeAlD
Ixabepilone—TUBB2B—nipple—breast cancer	0.000407	0.0272	CbGeAlD
Ixabepilone—TUBB4B—mammary gland—breast cancer	0.000397	0.0266	CbGeAlD
Ixabepilone—TUBB—nipple—breast cancer	0.000385	0.0258	CbGeAlD
Ixabepilone—TUBB2A—nipple—breast cancer	0.000383	0.0256	CbGeAlD
Ixabepilone—TUBB6—nipple—breast cancer	0.000378	0.0253	CbGeAlD
Ixabepilone—TUBB1—adipose tissue—breast cancer	0.000368	0.0246	CbGeAlD
Ixabepilone—CYP3A4—Raloxifene—breast cancer	0.000352	0.00117	CbGbCtD
Ixabepilone—TUBB4A—embryo—breast cancer	0.000347	0.0233	CbGeAlD
Ixabepilone—TUBB4B—nipple—breast cancer	0.000328	0.022	CbGeAlD
Ixabepilone—TUBB1—bone marrow—breast cancer	0.000319	0.0214	CbGeAlD
Ixabepilone—TUBB4B—embryo—breast cancer	0.000271	0.0181	CbGeAlD
Ixabepilone—TUBB4A—skin of body—breast cancer	0.00027	0.018	CbGeAlD
Ixabepilone—CYP3A4—Vinorelbine—breast cancer	0.000257	0.000858	CbGbCtD
Ixabepilone—TUBB6—epithelium—breast cancer	0.000254	0.017	CbGeAlD
Ixabepilone—TUBB2B—endometrium—breast cancer	0.000246	0.0164	CbGeAlD
Ixabepilone—TUBB2A—skin of body—breast cancer	0.000245	0.0164	CbGeAlD
Ixabepilone—TUBB6—skin of body—breast cancer	0.000242	0.0162	CbGeAlD
Ixabepilone—TUBB4A—uterus—breast cancer	0.000234	0.0157	CbGeAlD
Ixabepilone—CYP3A4—Tamoxifen—breast cancer	0.000232	0.000775	CbGbCtD
Ixabepilone—TUBB—endometrium—breast cancer	0.000232	0.0156	CbGeAlD
Ixabepilone—TUBB2A—endometrium—breast cancer	0.000231	0.0155	CbGeAlD
Ixabepilone—TUBB6—endometrium—breast cancer	0.000228	0.0153	CbGeAlD
Ixabepilone—CYP3A4—Mitoxantrone—breast cancer	0.000227	0.000756	CbGbCtD
Ixabepilone—TUBB2B—pituitary gland—breast cancer	0.000222	0.0149	CbGeAlD
Ixabepilone—TUBB2B—adipose tissue—breast cancer	0.000221	0.0148	CbGeAlD
Ixabepilone—TUBB6—Zalcitabine—Gemcitabine—breast cancer	0.000221	0.298	CbGdCrCtD
Ixabepilone—TUBB—uterus—breast cancer	0.000214	0.0143	CbGeAlD
Ixabepilone—TUBB2A—uterus—breast cancer	0.000213	0.0143	CbGeAlD
Ixabepilone—TUBB4A—female reproductive system—breast cancer	0.000211	0.0141	CbGeAlD
Ixabepilone—TUBB—pituitary gland—breast cancer	0.00021	0.0141	CbGeAlD
Ixabepilone—TUBB4B—skin of body—breast cancer	0.00021	0.0141	CbGeAlD
Ixabepilone—TUBB6—uterus—breast cancer	0.00021	0.0141	CbGeAlD
Ixabepilone—TUBB—adipose tissue—breast cancer	0.000209	0.014	CbGeAlD
Ixabepilone—TUBB2A—pituitary gland—breast cancer	0.000209	0.014	CbGeAlD
Ixabepilone—TUBB2A—adipose tissue—breast cancer	0.000208	0.014	CbGeAlD
Ixabepilone—TUBB6—pituitary gland—breast cancer	0.000206	0.0138	CbGeAlD
Ixabepilone—TUBB6—adipose tissue—breast cancer	0.000206	0.0138	CbGeAlD
Ixabepilone—TUBB4A—adrenal gland—breast cancer	0.000205	0.0138	CbGeAlD
Ixabepilone—TUBB2B—female reproductive system—breast cancer	0.000203	0.0136	CbGeAlD
Ixabepilone—TUBB2B—adrenal gland—breast cancer	0.000199	0.0133	CbGeAlD
Ixabepilone—TUBB4B—endometrium—breast cancer	0.000198	0.0133	CbGeAlD
Ixabepilone—TUBB4A—female gonad—breast cancer	0.000192	0.0128	CbGeAlD
Ixabepilone—TUBB2A—female reproductive system—breast cancer	0.000192	0.0128	CbGeAlD
Ixabepilone—TUBB6—female reproductive system—breast cancer	0.000189	0.0126	CbGeAlD
Ixabepilone—TUBB—adrenal gland—breast cancer	0.000188	0.0126	CbGeAlD
Ixabepilone—TUBB2A—adrenal gland—breast cancer	0.000187	0.0125	CbGeAlD
Ixabepilone—TUBB2B—female gonad—breast cancer	0.000185	0.0124	CbGeAlD
Ixabepilone—TUBB6—adrenal gland—breast cancer	0.000184	0.0123	CbGeAlD
Ixabepilone—TUBB4B—uterus—breast cancer	0.000183	0.0122	CbGeAlD
Ixabepilone—TUBB—bone marrow—breast cancer	0.000182	0.0122	CbGeAlD
Ixabepilone—CYP3A4—Paclitaxel—breast cancer	0.000181	0.000603	CbGbCtD
Ixabepilone—TUBB2A—bone marrow—breast cancer	0.000181	0.0121	CbGeAlD
Ixabepilone—TUBB4B—pituitary gland—breast cancer	0.000179	0.012	CbGeAlD
Ixabepilone—TUBB4B—adipose tissue—breast cancer	0.000179	0.012	CbGeAlD
Ixabepilone—CYP3A4—Irinotecan—breast cancer	0.000178	0.000595	CbGbCtD
Ixabepilone—TUBB6—bone marrow—breast cancer	0.000178	0.0119	CbGeAlD
Ixabepilone—TUBB4A—endocrine gland—breast cancer	0.000178	0.0119	CbGeAlD
Ixabepilone—TUBB—female gonad—breast cancer	0.000175	0.0117	CbGeAlD
Ixabepilone—TUBB2A—female gonad—breast cancer	0.000174	0.0117	CbGeAlD
Ixabepilone—TUBB2B—endocrine gland—breast cancer	0.000172	0.0115	CbGeAlD
Ixabepilone—TUBB6—female gonad—breast cancer	0.000172	0.0115	CbGeAlD
Ixabepilone—TUBB4B—female reproductive system—breast cancer	0.000164	0.011	CbGeAlD
Ixabepilone—TUBB2A—endocrine gland—breast cancer	0.000162	0.0109	CbGeAlD
Ixabepilone—TUBB4B—adrenal gland—breast cancer	0.00016	0.0107	CbGeAlD
Ixabepilone—TUBB6—endocrine gland—breast cancer	0.00016	0.0107	CbGeAlD
Ixabepilone—CYP3A4—Vinblastine—breast cancer	0.000159	0.000529	CbGbCtD
Ixabepilone—TUBB4B—bone marrow—breast cancer	0.000155	0.0104	CbGeAlD
Ixabepilone—TUBB4B—female gonad—breast cancer	0.000149	0.01	CbGeAlD
Ixabepilone—TUBB4B—endocrine gland—breast cancer	0.000139	0.0093	CbGeAlD
Ixabepilone—CYP3A4—Docetaxel—breast cancer	0.000131	0.000436	CbGbCtD
Ixabepilone—TUBB6—Clomifene—Toremifene—breast cancer	0.000125	0.169	CbGdCrCtD
Ixabepilone—TUBB4A—lymph node—breast cancer	0.000123	0.00825	CbGeAlD
Ixabepilone—TUBB2B—lymph node—breast cancer	0.000119	0.00797	CbGeAlD
Ixabepilone—TUBB—lymph node—breast cancer	0.000113	0.00754	CbGeAlD
Ixabepilone—TUBB—Azacitidine—Gemcitabine—breast cancer	0.000112	0.152	CbGdCrCtD
Ixabepilone—TUBB2A—lymph node—breast cancer	0.000112	0.0075	CbGeAlD
Ixabepilone—TUBB6—lymph node—breast cancer	0.00011	0.0074	CbGeAlD
Ixabepilone—CYP3A4—Doxorubicin—breast cancer	9.75e-05	0.000325	CbGbCtD
Ixabepilone—TUBB4B—lymph node—breast cancer	9.61e-05	0.00643	CbGeAlD
Ixabepilone—TUBB6—Tamoxifen—Toremifene—breast cancer	8.03e-05	0.109	CbGdCrCtD
Ixabepilone—TUBB6—Clomifene—Tamoxifen—breast cancer	7.86e-05	0.106	CbGdCrCtD
Ixabepilone—TUBB6—Toremifene—Tamoxifen—breast cancer	7.67e-05	0.104	CbGdCrCtD
Ixabepilone—CYP3A4—female reproductive system—breast cancer	6.75e-05	0.00452	CbGeAlD
Ixabepilone—CYP3A4—endocrine gland—breast cancer	5.71e-05	0.00382	CbGeAlD
Ixabepilone—TUBB6—Azacitidine—Gemcitabine—breast cancer	4.64e-05	0.0627	CbGdCrCtD
Ixabepilone—Renal failure—Doxorubicin—breast cancer	1.09e-05	0.000189	CcSEcCtD
Ixabepilone—Infection—Capecitabine—breast cancer	1.09e-05	0.000189	CcSEcCtD
Ixabepilone—Erythema multiforme—Methotrexate—breast cancer	1.08e-05	0.000188	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—breast cancer	1.08e-05	0.000188	CcSEcCtD
Ixabepilone—Dizziness—Irinotecan—breast cancer	1.08e-05	0.000188	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—breast cancer	1.08e-05	0.000187	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—breast cancer	1.08e-05	0.000187	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—breast cancer	1.08e-05	0.000187	CcSEcCtD
Ixabepilone—Anorexia—Docetaxel—breast cancer	1.08e-05	0.000187	CcSEcCtD
Ixabepilone—Shock—Capecitabine—breast cancer	1.08e-05	0.000187	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—breast cancer	1.07e-05	0.000187	CcSEcCtD
Ixabepilone—Nervous system disorder—Capecitabine—breast cancer	1.07e-05	0.000186	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—breast cancer	1.07e-05	0.000186	CcSEcCtD
Ixabepilone—Eye disorder—Methotrexate—breast cancer	1.07e-05	0.000186	CcSEcCtD
Ixabepilone—Diarrhoea—Fluorouracil—breast cancer	1.07e-05	0.000186	CcSEcCtD
Ixabepilone—Thrombocytopenia—Capecitabine—breast cancer	1.07e-05	0.000186	CcSEcCtD
Ixabepilone—Hypoaesthesia—Epirubicin—breast cancer	1.07e-05	0.000185	CcSEcCtD
Ixabepilone—Cardiac disorder—Methotrexate—breast cancer	1.06e-05	0.000185	CcSEcCtD
Ixabepilone—Skin disorder—Capecitabine—breast cancer	1.06e-05	0.000185	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—breast cancer	1.06e-05	0.000184	CcSEcCtD
Ixabepilone—Hypotension—Docetaxel—breast cancer	1.06e-05	0.000183	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—breast cancer	1.05e-05	0.000183	CcSEcCtD
Ixabepilone—Abdominal pain—Paclitaxel—breast cancer	1.05e-05	0.000183	CcSEcCtD
Ixabepilone—Body temperature increased—Paclitaxel—breast cancer	1.05e-05	0.000183	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—breast cancer	1.05e-05	0.000183	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—breast cancer	1.05e-05	0.000182	CcSEcCtD
Ixabepilone—Anorexia—Capecitabine—breast cancer	1.04e-05	0.000181	CcSEcCtD
Ixabepilone—Angiopathy—Methotrexate—breast cancer	1.04e-05	0.000181	CcSEcCtD
Ixabepilone—Vomiting—Mitoxantrone—breast cancer	1.04e-05	0.00018	CcSEcCtD
Ixabepilone—Vomiting—Irinotecan—breast cancer	1.04e-05	0.00018	CcSEcCtD
Ixabepilone—Immune system disorder—Methotrexate—breast cancer	1.04e-05	0.00018	CcSEcCtD
Ixabepilone—Dizziness—Fluorouracil—breast cancer	1.04e-05	0.00018	CcSEcCtD
Ixabepilone—Mediastinal disorder—Methotrexate—breast cancer	1.03e-05	0.000179	CcSEcCtD
Ixabepilone—Rash—Mitoxantrone—breast cancer	1.03e-05	0.000179	CcSEcCtD
Ixabepilone—Rash—Irinotecan—breast cancer	1.03e-05	0.000179	CcSEcCtD
Ixabepilone—Dermatitis—Irinotecan—breast cancer	1.03e-05	0.000179	CcSEcCtD
Ixabepilone—Dermatitis—Mitoxantrone—breast cancer	1.03e-05	0.000179	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Docetaxel—breast cancer	1.03e-05	0.000179	CcSEcCtD
Ixabepilone—Chills—Methotrexate—breast cancer	1.03e-05	0.000179	CcSEcCtD
Ixabepilone—Headache—Mitoxantrone—breast cancer	1.02e-05	0.000178	CcSEcCtD
Ixabepilone—Headache—Irinotecan—breast cancer	1.02e-05	0.000178	CcSEcCtD
Ixabepilone—Hypotension—Capecitabine—breast cancer	1.02e-05	0.000178	CcSEcCtD
Ixabepilone—Insomnia—Docetaxel—breast cancer	1.02e-05	0.000177	CcSEcCtD
Ixabepilone—Paraesthesia—Docetaxel—breast cancer	1.01e-05	0.000176	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—breast cancer	1.01e-05	0.000176	CcSEcCtD
Ixabepilone—Alopecia—Methotrexate—breast cancer	1.01e-05	0.000176	CcSEcCtD
Ixabepilone—Vomiting—Gemcitabine—breast cancer	1.01e-05	0.000176	CcSEcCtD
Ixabepilone—Dyspnoea—Docetaxel—breast cancer	1.01e-05	0.000175	CcSEcCtD
Ixabepilone—Mental disorder—Methotrexate—breast cancer	1e-05	0.000174	CcSEcCtD
Ixabepilone—Rash—Gemcitabine—breast cancer	1e-05	0.000174	CcSEcCtD
Ixabepilone—Dermatitis—Gemcitabine—breast cancer	1e-05	0.000174	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—breast cancer	1e-05	0.000174	CcSEcCtD
Ixabepilone—Malnutrition—Methotrexate—breast cancer	9.98e-06	0.000173	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—breast cancer	9.97e-06	0.000173	CcSEcCtD
Ixabepilone—Headache—Gemcitabine—breast cancer	9.97e-06	0.000173	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Capecitabine—breast cancer	9.96e-06	0.000173	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—breast cancer	9.95e-06	0.000173	CcSEcCtD
Ixabepilone—Vomiting—Fluorouracil—breast cancer	9.95e-06	0.000173	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—breast cancer	9.92e-06	0.000172	CcSEcCtD
Ixabepilone—Insomnia—Capecitabine—breast cancer	9.89e-06	0.000172	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—breast cancer	9.87e-06	0.000172	CcSEcCtD
Ixabepilone—Rash—Fluorouracil—breast cancer	9.87e-06	0.000171	CcSEcCtD
Ixabepilone—Dermatitis—Fluorouracil—breast cancer	9.86e-06	0.000171	CcSEcCtD
Ixabepilone—Paraesthesia—Capecitabine—breast cancer	9.82e-06	0.000171	CcSEcCtD
Ixabepilone—Decreased appetite—Docetaxel—breast cancer	9.82e-06	0.000171	CcSEcCtD
Ixabepilone—Hypersensitivity—Paclitaxel—breast cancer	9.82e-06	0.000171	CcSEcCtD
Ixabepilone—Headache—Fluorouracil—breast cancer	9.81e-06	0.00017	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—breast cancer	9.8e-06	0.00017	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Docetaxel—breast cancer	9.75e-06	0.000169	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—breast cancer	9.75e-06	0.000169	CcSEcCtD
Ixabepilone—Dyspnoea—Capecitabine—breast cancer	9.75e-06	0.000169	CcSEcCtD
Ixabepilone—Fatigue—Docetaxel—breast cancer	9.74e-06	0.000169	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—breast cancer	9.73e-06	0.000169	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—breast cancer	9.73e-06	0.000169	CcSEcCtD
Ixabepilone—Nausea—Irinotecan—breast cancer	9.71e-06	0.000169	CcSEcCtD
Ixabepilone—Nausea—Mitoxantrone—breast cancer	9.71e-06	0.000169	CcSEcCtD
Ixabepilone—Immune system disorder—Epirubicin—breast cancer	9.69e-06	0.000168	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—breast cancer	9.67e-06	0.000168	CcSEcCtD
Ixabepilone—Pain—Docetaxel—breast cancer	9.66e-06	0.000168	CcSEcCtD
Ixabepilone—Constipation—Docetaxel—breast cancer	9.66e-06	0.000168	CcSEcCtD
Ixabepilone—Chills—Epirubicin—breast cancer	9.62e-06	0.000167	CcSEcCtD
Ixabepilone—Asthenia—Paclitaxel—breast cancer	9.56e-06	0.000166	CcSEcCtD
Ixabepilone—Decreased appetite—Capecitabine—breast cancer	9.51e-06	0.000165	CcSEcCtD
Ixabepilone—Alopecia—Epirubicin—breast cancer	9.48e-06	0.000165	CcSEcCtD
Ixabepilone—Nausea—Gemcitabine—breast cancer	9.46e-06	0.000164	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Capecitabine—breast cancer	9.44e-06	0.000164	CcSEcCtD
Ixabepilone—Fatigue—Capecitabine—breast cancer	9.43e-06	0.000164	CcSEcCtD
Ixabepilone—Pruritus—Paclitaxel—breast cancer	9.43e-06	0.000164	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—breast cancer	9.4e-06	0.000163	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—breast cancer	9.38e-06	0.000163	CcSEcCtD
Ixabepilone—Pain—Capecitabine—breast cancer	9.35e-06	0.000162	CcSEcCtD
Ixabepilone—Constipation—Capecitabine—breast cancer	9.35e-06	0.000162	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—breast cancer	9.34e-06	0.000162	CcSEcCtD
Ixabepilone—Nausea—Fluorouracil—breast cancer	9.3e-06	0.000161	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—breast cancer	9.27e-06	0.000161	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Docetaxel—breast cancer	9.24e-06	0.00016	CcSEcCtD
Ixabepilone—Anaemia—Methotrexate—breast cancer	9.22e-06	0.00016	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—breast cancer	9.21e-06	0.00016	CcSEcCtD
Ixabepilone—Diarrhoea—Paclitaxel—breast cancer	9.12e-06	0.000158	CcSEcCtD
Ixabepilone—Angiopathy—Doxorubicin—breast cancer	9e-06	0.000156	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—breast cancer	8.98e-06	0.000156	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—breast cancer	8.96e-06	0.000156	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Capecitabine—breast cancer	8.94e-06	0.000155	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—breast cancer	8.94e-06	0.000155	CcSEcCtD
Ixabepilone—Body temperature increased—Docetaxel—breast cancer	8.93e-06	0.000155	CcSEcCtD
Ixabepilone—Abdominal pain—Docetaxel—breast cancer	8.93e-06	0.000155	CcSEcCtD
Ixabepilone—Leukopenia—Methotrexate—breast cancer	8.93e-06	0.000155	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—breast cancer	8.9e-06	0.000155	CcSEcCtD
Ixabepilone—Dizziness—Paclitaxel—breast cancer	8.81e-06	0.000153	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—breast cancer	8.77e-06	0.000152	CcSEcCtD
Ixabepilone—Cough—Methotrexate—breast cancer	8.71e-06	0.000151	CcSEcCtD
Ixabepilone—Mental disorder—Doxorubicin—breast cancer	8.69e-06	0.000151	CcSEcCtD
Ixabepilone—Abdominal pain—Capecitabine—breast cancer	8.65e-06	0.00015	CcSEcCtD
Ixabepilone—Body temperature increased—Capecitabine—breast cancer	8.65e-06	0.00015	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—breast cancer	8.64e-06	0.00015	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—breast cancer	8.63e-06	0.00015	CcSEcCtD
Ixabepilone—Arthralgia—Methotrexate—breast cancer	8.49e-06	0.000148	CcSEcCtD
Ixabepilone—Chest pain—Methotrexate—breast cancer	8.49e-06	0.000148	CcSEcCtD
Ixabepilone—Myalgia—Methotrexate—breast cancer	8.49e-06	0.000148	CcSEcCtD
Ixabepilone—Vomiting—Paclitaxel—breast cancer	8.47e-06	0.000147	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.44e-06	0.000147	CcSEcCtD
Ixabepilone—Rash—Paclitaxel—breast cancer	8.4e-06	0.000146	CcSEcCtD
Ixabepilone—Dermatitis—Paclitaxel—breast cancer	8.4e-06	0.000146	CcSEcCtD
Ixabepilone—Syncope—Epirubicin—breast cancer	8.37e-06	0.000145	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—breast cancer	8.36e-06	0.000145	CcSEcCtD
Ixabepilone—Headache—Paclitaxel—breast cancer	8.35e-06	0.000145	CcSEcCtD
Ixabepilone—Hypersensitivity—Docetaxel—breast cancer	8.32e-06	0.000145	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—breast cancer	8.31e-06	0.000144	CcSEcCtD
Ixabepilone—Loss of consciousness—Epirubicin—breast cancer	8.21e-06	0.000143	CcSEcCtD
Ixabepilone—Cough—Epirubicin—breast cancer	8.15e-06	0.000142	CcSEcCtD
Ixabepilone—Asthenia—Docetaxel—breast cancer	8.11e-06	0.000141	CcSEcCtD
Ixabepilone—Infection—Methotrexate—breast cancer	8.09e-06	0.000141	CcSEcCtD
Ixabepilone—Hypersensitivity—Capecitabine—breast cancer	8.06e-06	0.00014	CcSEcCtD
Ixabepilone—Pruritus—Docetaxel—breast cancer	7.99e-06	0.000139	CcSEcCtD
Ixabepilone—Nervous system disorder—Methotrexate—breast cancer	7.98e-06	0.000139	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—breast cancer	7.98e-06	0.000139	CcSEcCtD
Ixabepilone—Thrombocytopenia—Methotrexate—breast cancer	7.97e-06	0.000138	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—breast cancer	7.95e-06	0.000138	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—breast cancer	7.95e-06	0.000138	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—breast cancer	7.95e-06	0.000138	CcSEcCtD
Ixabepilone—Nausea—Paclitaxel—breast cancer	7.92e-06	0.000138	CcSEcCtD
Ixabepilone—Skin disorder—Methotrexate—breast cancer	7.91e-06	0.000137	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	7.89e-06	0.000137	CcSEcCtD
Ixabepilone—Asthenia—Capecitabine—breast cancer	7.85e-06	0.000136	CcSEcCtD
Ixabepilone—Anorexia—Methotrexate—breast cancer	7.76e-06	0.000135	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—breast cancer	7.75e-06	0.000135	CcSEcCtD
Ixabepilone—Pruritus—Capecitabine—breast cancer	7.74e-06	0.000134	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—breast cancer	7.73e-06	0.000134	CcSEcCtD
Ixabepilone—Diarrhoea—Docetaxel—breast cancer	7.73e-06	0.000134	CcSEcCtD
Ixabepilone—Oedema—Epirubicin—breast cancer	7.62e-06	0.000132	CcSEcCtD
Ixabepilone—Hypotension—Methotrexate—breast cancer	7.61e-06	0.000132	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—breast cancer	7.59e-06	0.000132	CcSEcCtD
Ixabepilone—Infection—Epirubicin—breast cancer	7.57e-06	0.000131	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—breast cancer	7.54e-06	0.000131	CcSEcCtD
Ixabepilone—Shock—Epirubicin—breast cancer	7.5e-06	0.00013	CcSEcCtD
Ixabepilone—Diarrhoea—Capecitabine—breast cancer	7.48e-06	0.00013	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—breast cancer	7.47e-06	0.00013	CcSEcCtD
Ixabepilone—Dizziness—Docetaxel—breast cancer	7.47e-06	0.00013	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—breast cancer	7.46e-06	0.00013	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Methotrexate—breast cancer	7.42e-06	0.000129	CcSEcCtD
Ixabepilone—Skin disorder—Epirubicin—breast cancer	7.4e-06	0.000129	CcSEcCtD
Ixabepilone—Insomnia—Methotrexate—breast cancer	7.36e-06	0.000128	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—breast cancer	7.35e-06	0.000128	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—breast cancer	7.35e-06	0.000128	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—breast cancer	7.35e-06	0.000128	CcSEcCtD
Ixabepilone—Paraesthesia—Methotrexate—breast cancer	7.31e-06	0.000127	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.3e-06	0.000127	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—breast cancer	7.26e-06	0.000126	CcSEcCtD
Ixabepilone—Dyspnoea—Methotrexate—breast cancer	7.26e-06	0.000126	CcSEcCtD
Ixabepilone—Dizziness—Capecitabine—breast cancer	7.23e-06	0.000126	CcSEcCtD
Ixabepilone—Vomiting—Docetaxel—breast cancer	7.18e-06	0.000125	CcSEcCtD
Ixabepilone—Rash—Docetaxel—breast cancer	7.12e-06	0.000124	CcSEcCtD
Ixabepilone—Hypotension—Epirubicin—breast cancer	7.12e-06	0.000124	CcSEcCtD
Ixabepilone—Dermatitis—Docetaxel—breast cancer	7.12e-06	0.000124	CcSEcCtD
Ixabepilone—Decreased appetite—Methotrexate—breast cancer	7.08e-06	0.000123	CcSEcCtD
Ixabepilone—Headache—Docetaxel—breast cancer	7.08e-06	0.000123	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—breast cancer	7.05e-06	0.000122	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Methotrexate—breast cancer	7.03e-06	0.000122	CcSEcCtD
Ixabepilone—Fatigue—Methotrexate—breast cancer	7.02e-06	0.000122	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—breast cancer	7e-06	0.000122	CcSEcCtD
Ixabepilone—Pain—Methotrexate—breast cancer	6.96e-06	0.000121	CcSEcCtD
Ixabepilone—Vomiting—Capecitabine—breast cancer	6.95e-06	0.000121	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—breast cancer	6.94e-06	0.000121	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—breast cancer	6.94e-06	0.00012	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—breast cancer	6.91e-06	0.00012	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—breast cancer	6.9e-06	0.00012	CcSEcCtD
Ixabepilone—Rash—Capecitabine—breast cancer	6.9e-06	0.00012	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—breast cancer	6.89e-06	0.00012	CcSEcCtD
Ixabepilone—Dermatitis—Capecitabine—breast cancer	6.89e-06	0.00012	CcSEcCtD
Ixabepilone—Headache—Capecitabine—breast cancer	6.85e-06	0.000119	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—breast cancer	6.85e-06	0.000119	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—breast cancer	6.84e-06	0.000119	CcSEcCtD
Ixabepilone—Dyspnoea—Epirubicin—breast cancer	6.79e-06	0.000118	CcSEcCtD
Ixabepilone—Anorexia—Doxorubicin—breast cancer	6.72e-06	0.000117	CcSEcCtD
Ixabepilone—Nausea—Docetaxel—breast cancer	6.71e-06	0.000117	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Methotrexate—breast cancer	6.66e-06	0.000116	CcSEcCtD
Ixabepilone—Decreased appetite—Epirubicin—breast cancer	6.62e-06	0.000115	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—breast cancer	6.59e-06	0.000114	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—breast cancer	6.58e-06	0.000114	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—breast cancer	6.57e-06	0.000114	CcSEcCtD
Ixabepilone—Pain—Epirubicin—breast cancer	6.52e-06	0.000113	CcSEcCtD
Ixabepilone—Constipation—Epirubicin—breast cancer	6.52e-06	0.000113	CcSEcCtD
Ixabepilone—Nausea—Capecitabine—breast cancer	6.5e-06	0.000113	CcSEcCtD
Ixabepilone—Body temperature increased—Methotrexate—breast cancer	6.44e-06	0.000112	CcSEcCtD
Ixabepilone—Abdominal pain—Methotrexate—breast cancer	6.44e-06	0.000112	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.42e-06	0.000112	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—breast cancer	6.38e-06	0.000111	CcSEcCtD
Ixabepilone—Paraesthesia—Doxorubicin—breast cancer	6.33e-06	0.00011	CcSEcCtD
Ixabepilone—Dyspnoea—Doxorubicin—breast cancer	6.29e-06	0.000109	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Epirubicin—breast cancer	6.23e-06	0.000108	CcSEcCtD
Ixabepilone—Decreased appetite—Doxorubicin—breast cancer	6.13e-06	0.000106	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—breast cancer	6.09e-06	0.000106	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—breast cancer	6.08e-06	0.000106	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—breast cancer	6.03e-06	0.000105	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—breast cancer	6.03e-06	0.000105	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—breast cancer	6.02e-06	0.000105	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—breast cancer	6.02e-06	0.000105	CcSEcCtD
Ixabepilone—Hypersensitivity—Methotrexate—breast cancer	6e-06	0.000104	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—PLG—breast cancer	5.94e-06	0.000183	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—E2F1—breast cancer	5.93e-06	0.000182	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	5.92e-06	0.000182	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—ATM—breast cancer	5.86e-06	0.00018	CbGpPWpGaD
Ixabepilone—Asthenia—Methotrexate—breast cancer	5.84e-06	0.000101	CcSEcCtD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	5.84e-06	0.000179	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDK4—breast cancer	5.83e-06	0.000179	CbGpPWpGaD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	5.8e-06	0.000178	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ABCB1—breast cancer	5.79e-06	0.000178	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCNE1—breast cancer	5.77e-06	0.000177	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—breast cancer	5.77e-06	0.0001	CcSEcCtD
Ixabepilone—Pruritus—Methotrexate—breast cancer	5.76e-06	0.0001	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—GSTA4—breast cancer	5.74e-06	0.000176	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	5.73e-06	0.000176	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDK2—breast cancer	5.72e-06	0.000176	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—BIRC5—breast cancer	5.7e-06	0.000175	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RB1—breast cancer	5.67e-06	0.000174	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TYMS—breast cancer	5.67e-06	0.000174	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	5.66e-06	0.000174	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Epirubicin—breast cancer	5.61e-06	9.75e-05	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—GSTA2—breast cancer	5.59e-06	0.000172	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—BIRC5—breast cancer	5.58e-06	0.000171	CbGpPWpGaD
Ixabepilone—Abdominal pain—Doxorubicin—breast cancer	5.57e-06	9.68e-05	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—breast cancer	5.57e-06	9.68e-05	CcSEcCtD
Ixabepilone—Diarrhoea—Methotrexate—breast cancer	5.57e-06	9.68e-05	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—PLAUR—breast cancer	5.56e-06	0.000171	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—SULT1A1—breast cancer	5.53e-06	0.00017	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	5.52e-06	0.00017	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—HMOX1—breast cancer	5.52e-06	0.00017	CbGpPWpGaD
Ixabepilone—Asthenia—Epirubicin—breast cancer	5.47e-06	9.5e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—H2AFX—breast cancer	5.46e-06	0.000168	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	5.45e-06	0.000168	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	5.45e-06	0.000168	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—PLG—breast cancer	5.43e-06	0.000167	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—E2F1—breast cancer	5.42e-06	0.000167	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDK4—breast cancer	5.41e-06	0.000166	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TERT—breast cancer	5.4e-06	0.000166	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTA1—breast cancer	5.4e-06	0.000166	CbGpPWpGaD
Ixabepilone—Pruritus—Epirubicin—breast cancer	5.39e-06	9.36e-05	CcSEcCtD
Ixabepilone—Dizziness—Methotrexate—breast cancer	5.38e-06	9.35e-05	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—NAT2—breast cancer	5.34e-06	0.000164	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ABCB1—breast cancer	5.3e-06	0.000163	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MMP1—breast cancer	5.29e-06	0.000163	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—MMP1—breast cancer	5.29e-06	0.000163	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	5.26e-06	0.000162	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDK2—breast cancer	5.23e-06	0.000161	CbGpPWpGaD
Ixabepilone—Diarrhoea—Epirubicin—breast cancer	5.21e-06	9.06e-05	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—breast cancer	5.19e-06	9.02e-05	CcSEcCtD
Ixabepilone—Vomiting—Methotrexate—breast cancer	5.18e-06	8.99e-05	CcSEcCtD
Ixabepilone—Rash—Methotrexate—breast cancer	5.13e-06	8.92e-05	CcSEcCtD
Ixabepilone—Dermatitis—Methotrexate—breast cancer	5.13e-06	8.91e-05	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—LEP—breast cancer	5.12e-06	0.000157	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—LEP—breast cancer	5.12e-06	0.000157	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDK2—breast cancer	5.11e-06	0.000157	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—MMP1—breast cancer	5.11e-06	0.000157	CbGpPWpGaD
Ixabepilone—Headache—Methotrexate—breast cancer	5.1e-06	8.86e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—BIRC5—breast cancer	5.1e-06	0.000157	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—RB1—breast cancer	5.07e-06	0.000156	CbGpPWpGaD
Ixabepilone—Asthenia—Doxorubicin—breast cancer	5.06e-06	8.79e-05	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—breast cancer	5.04e-06	8.75e-05	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—breast cancer	4.99e-06	8.66e-05	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—MMP1—breast cancer	4.95e-06	0.000152	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDK4—breast cancer	4.94e-06	0.000152	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—LEP—breast cancer	4.94e-06	0.000152	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TERT—breast cancer	4.94e-06	0.000152	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—ATM—breast cancer	4.85e-06	0.000149	CbGpPWpGaD
Ixabepilone—Vomiting—Epirubicin—breast cancer	4.84e-06	8.42e-05	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—MMP1—breast cancer	4.84e-06	0.000149	CbGpPWpGaD
Ixabepilone—Nausea—Methotrexate—breast cancer	4.84e-06	8.4e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CDK4—breast cancer	4.83e-06	0.000149	CbGpPWpGaD
Ixabepilone—Diarrhoea—Doxorubicin—breast cancer	4.82e-06	8.38e-05	CcSEcCtD
Ixabepilone—Rash—Epirubicin—breast cancer	4.8e-06	8.34e-05	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—breast cancer	4.8e-06	8.34e-05	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—LEP—breast cancer	4.79e-06	0.000147	CbGpPWpGaD
Ixabepilone—Headache—Epirubicin—breast cancer	4.77e-06	8.29e-05	CcSEcCtD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	4.7e-06	0.000145	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RB1—breast cancer	4.7e-06	0.000144	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—LEP—breast cancer	4.68e-06	0.000144	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDK2—breast cancer	4.68e-06	0.000144	CbGpPWpGaD
Ixabepilone—Dizziness—Doxorubicin—breast cancer	4.66e-06	8.1e-05	CcSEcCtD
Ixabepilone—Nausea—Epirubicin—breast cancer	4.53e-06	7.86e-05	CcSEcCtD
Ixabepilone—Vomiting—Doxorubicin—breast cancer	4.48e-06	7.79e-05	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—breast cancer	4.45e-06	7.72e-05	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—breast cancer	4.44e-06	7.71e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—ATM—breast cancer	4.44e-06	0.000136	CbGpPWpGaD
Ixabepilone—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	4.43e-06	0.000136	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDK4—breast cancer	4.42e-06	0.000136	CbGpPWpGaD
Ixabepilone—Headache—Doxorubicin—breast cancer	4.42e-06	7.67e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1B—breast cancer	4.42e-06	0.000136	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ALB—breast cancer	4.41e-06	0.000136	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ALB—breast cancer	4.41e-06	0.000136	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—MTR—breast cancer	4.35e-06	0.000134	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—MMP1—breast cancer	4.34e-06	0.000133	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MDM2—breast cancer	4.32e-06	0.000133	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RB1—breast cancer	4.3e-06	0.000132	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—HPGDS—breast cancer	4.27e-06	0.000131	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ALB—breast cancer	4.26e-06	0.000131	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—IGF1—breast cancer	4.23e-06	0.00013	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—IGF1—breast cancer	4.23e-06	0.00013	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—breast cancer	4.21e-06	0.000129	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—RB1—breast cancer	4.2e-06	0.000129	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—LEP—breast cancer	4.2e-06	0.000129	CbGpPWpGaD
Ixabepilone—Nausea—Doxorubicin—breast cancer	4.19e-06	7.27e-05	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—GSTT1—breast cancer	4.14e-06	0.000127	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ALB—breast cancer	4.13e-06	0.000127	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—MMP2—breast cancer	4.09e-06	0.000126	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MMP2—breast cancer	4.09e-06	0.000126	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—IGF1—breast cancer	4.08e-06	0.000126	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1A—breast cancer	4.08e-06	0.000125	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ALB—breast cancer	4.03e-06	0.000124	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—RAF1—breast cancer	3.99e-06	0.000123	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—RAF1—breast cancer	3.99e-06	0.000123	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—MMP1—breast cancer	3.97e-06	0.000122	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—IGF1—breast cancer	3.96e-06	0.000122	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—MMP2—breast cancer	3.95e-06	0.000121	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1B—breast cancer	3.95e-06	0.000121	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP17A1—breast cancer	3.92e-06	0.00012	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—PTGS1—breast cancer	3.88e-06	0.000119	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—IGF1—breast cancer	3.87e-06	0.000119	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	3.86e-06	0.000119	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—RAF1—breast cancer	3.85e-06	0.000118	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—RB1—breast cancer	3.84e-06	0.000118	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—LEP—breast cancer	3.84e-06	0.000118	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—MMP2—breast cancer	3.83e-06	0.000118	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP2D6—breast cancer	3.8e-06	0.000117	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—breast cancer	3.77e-06	0.000116	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	3.75e-06	0.000115	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—MMP2—breast cancer	3.74e-06	0.000115	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—NCOA2—breast cancer	3.73e-06	0.000115	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—RAF1—breast cancer	3.73e-06	0.000115	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1B—breast cancer	3.66e-06	0.000112	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.65e-06	0.000112	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1A—breast cancer	3.64e-06	0.000112	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ALB—breast cancer	3.62e-06	0.000111	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MDM2—breast cancer	3.58e-06	0.00011	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—breast cancer	3.49e-06	0.000107	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MAPK3—breast cancer	3.47e-06	0.000107	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—IGF1—breast cancer	3.47e-06	0.000107	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CXCL8—breast cancer	3.4e-06	0.000105	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CXCL8—breast cancer	3.4e-06	0.000105	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MYC—breast cancer	3.38e-06	0.000104	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1A—breast cancer	3.38e-06	0.000104	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—MMP2—breast cancer	3.36e-06	0.000103	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1B—breast cancer	3.35e-06	0.000103	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ALB—breast cancer	3.31e-06	0.000102	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP1B1—breast cancer	3.3e-06	0.000101	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CXCL8—breast cancer	3.28e-06	0.000101	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MDM2—breast cancer	3.28e-06	0.000101	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—RAF1—breast cancer	3.28e-06	0.000101	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1B—breast cancer	3.27e-06	0.000101	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	3.25e-06	0.0001	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—breast cancer	3.19e-06	9.81e-05	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CXCL8—breast cancer	3.18e-06	9.78e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—IGF1—breast cancer	3.18e-06	9.76e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—NCOA1—breast cancer	3.15e-06	9.67e-05	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CTNNB1—breast cancer	3.14e-06	9.64e-05	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CTNNB1—breast cancer	3.14e-06	9.64e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—breast cancer	3.12e-06	9.59e-05	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CXCL8—breast cancer	3.11e-06	9.56e-05	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MAPK3—breast cancer	3.11e-06	9.55e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP19A1—breast cancer	3.1e-06	9.53e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1A—breast cancer	3.09e-06	9.49e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—MMP2—breast cancer	3.07e-06	9.45e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	3.06e-06	9.4e-05	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CTNNB1—breast cancer	3.03e-06	9.31e-05	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MYC—breast cancer	3.02e-06	9.29e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1A—breast cancer	3.02e-06	9.28e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—RAF1—breast cancer	3e-06	9.21e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1B—breast cancer	2.99e-06	9.2e-05	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CTNNB1—breast cancer	2.93e-06	9.02e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—COMT—breast cancer	2.88e-06	8.86e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MAPK3—breast cancer	2.88e-06	8.85e-05	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CTNNB1—breast cancer	2.87e-06	8.82e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.87e-06	8.82e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—breast cancer	2.85e-06	8.77e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.84e-06	8.74e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.83e-06	8.7e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MYC—breast cancer	2.8e-06	8.61e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CXCL8—breast cancer	2.79e-06	8.58e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1A—breast cancer	2.76e-06	8.49e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.64e-06	8.1e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MAPK3—breast cancer	2.63e-06	8.09e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.6e-06	7.99e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CTNNB1—breast cancer	2.58e-06	7.92e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MAPK3—breast cancer	2.57e-06	7.91e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MYC—breast cancer	2.56e-06	7.87e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CXCL8—breast cancer	2.55e-06	7.85e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MYC—breast cancer	2.5e-06	7.7e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP1A1—breast cancer	2.5e-06	7.68e-05	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—breast cancer	2.48e-06	7.63e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	2.46e-06	7.57e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CTNNB1—breast cancer	2.36e-06	7.24e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MAPK3—breast cancer	2.35e-06	7.24e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MYC—breast cancer	2.29e-06	7.04e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—breast cancer	2.06e-06	6.32e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SYNJ2—breast cancer	2.01e-06	6.18e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—breast cancer	1.88e-06	5.78e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NDUFS3—breast cancer	1.87e-06	5.74e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CHST9—breast cancer	1.76e-06	5.4e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—COX11—breast cancer	1.67e-06	5.12e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CDA—breast cancer	1.52e-06	4.68e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SHMT1—breast cancer	1.52e-06	4.68e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.47e-06	4.51e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC2A5—breast cancer	1.47e-06	4.51e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—APRT—breast cancer	1.42e-06	4.35e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ESRRA—breast cancer	1.33e-06	4.09e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.33e-06	4.09e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HADHB—breast cancer	1.26e-06	3.88e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GPI—breast cancer	1.26e-06	3.88e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.2e-06	3.7e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.2e-06	3.7e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NME1—breast cancer	1.15e-06	3.55e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—FHL2—breast cancer	1.15e-06	3.55e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—UMPS—breast cancer	1.15e-06	3.55e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PHGDH—breast cancer	1.15e-06	3.55e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ADSL—breast cancer	1.15e-06	3.55e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HPSE—breast cancer	1.13e-06	3.48e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—BRIP1—breast cancer	1.13e-06	3.48e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—LDHB—breast cancer	1.13e-06	3.48e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA3—breast cancer	1.07e-06	3.3e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCC1—breast cancer	1.07e-06	3.3e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HMMR—breast cancer	1.07e-06	3.3e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.04e-06	3.2e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CA9—breast cancer	9.82e-07	3.02e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA4—breast cancer	9.82e-07	3.02e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA2—breast cancer	9.57e-07	2.94e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GPX2—breast cancer	9.57e-07	2.94e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GPX4—breast cancer	9.45e-07	2.9e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SULT1A1—breast cancer	9.45e-07	2.9e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—IDH1—breast cancer	9.23e-07	2.84e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA1—breast cancer	9.23e-07	2.84e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NAT2—breast cancer	9.13e-07	2.81e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—DPYD—breast cancer	8e-07	2.46e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MED12—breast cancer	8e-07	2.46e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALDOA—breast cancer	7.88e-07	2.42e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOA3—breast cancer	7.65e-07	2.35e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC2A2—breast cancer	7.6e-07	2.33e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CPT1A—breast cancer	7.44e-07	2.29e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTR—breast cancer	7.44e-07	2.29e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCG2—breast cancer	7.44e-07	2.29e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HPGDS—breast cancer	7.3e-07	2.24e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HBA1—breast cancer	7.25e-07	2.23e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTT1—breast cancer	7.08e-07	2.18e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ACHE—breast cancer	7.08e-07	2.18e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP17A1—breast cancer	6.7e-07	2.06e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ENO1—breast cancer	6.63e-07	2.04e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS1—breast cancer	6.63e-07	2.04e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP2D6—breast cancer	6.5e-07	2e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOA2—breast cancer	6.38e-07	1.96e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—FASN—breast cancer	6.19e-07	1.9e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—BCHE—breast cancer	6.17e-07	1.89e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC5A5—breast cancer	6.09e-07	1.87e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NQO1—breast cancer	5.88e-07	1.81e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC2A1—breast cancer	5.88e-07	1.81e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP1B1—breast cancer	5.64e-07	1.73e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HSP90AA1—breast cancer	5.53e-07	1.7e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOA1—breast cancer	5.38e-07	1.65e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—STK11—breast cancer	5.3e-07	1.63e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP19A1—breast cancer	5.3e-07	1.63e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—COMT—breast cancer	4.93e-07	1.51e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTP1—breast cancer	4.91e-07	1.51e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HMOX1—breast cancer	4.84e-07	1.49e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ITPR1—breast cancer	4.83e-07	1.48e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCB1—breast cancer	4.64e-07	1.43e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TYMS—breast cancer	4.56e-07	1.4e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PLA2G4A—breast cancer	4.51e-07	1.39e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTM1—breast cancer	4.51e-07	1.39e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOR1—breast cancer	4.51e-07	1.39e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GPX1—breast cancer	4.32e-07	1.33e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP1A1—breast cancer	4.27e-07	1.31e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ERCC2—breast cancer	4.24e-07	1.3e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTHFR—breast cancer	3.98e-07	1.22e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CAV1—breast cancer	3.67e-07	1.13e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CG—breast cancer	3.35e-07	1.03e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CD—breast cancer	2.94e-07	9.04e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALB—breast cancer	2.91e-07	8.93e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NOS3—breast cancer	2.78e-07	8.54e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CB—breast cancer	2.56e-07	7.88e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS2—breast cancer	2.54e-07	7.81e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTEN—breast cancer	2.22e-07	6.81e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CA—breast cancer	1.56e-07	4.81e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKT1—breast cancer	1.28e-07	3.93e-06	CbGpPWpGaD
